tiprankstipranks
Trending News
More News >
Fuji Pharma Co., Ltd. (JP:4554)
:4554
Japanese Market

Fuji Pharma Co., Ltd. (4554) Income Statement

Compare
0 Followers

Fuji Pharma Co., Ltd. Income Statement

Last quarter (Q3 2025), Fuji Pharma Co., Ltd.'s total revenue was ¥12.86B, an increase of 9.28% from the same quarter last year. In Q3, Fuji Pharma Co., Ltd.'s net income was ¥543.00M. See Fuji Pharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 51.68B¥ 46.14B¥ 40.89B¥ 35.43B¥ 33.99B
Gross Profit
¥ 19.29B¥ 17.84B¥ 16.52B¥ 14.56B¥ 14.75B
Operating Expenses
¥ 14.30B¥ 13.96B¥ 12.66B¥ 10.78B¥ 11.40B
Depreciation and Amortization
¥ 3.96B¥ 3.68B¥ 3.02B¥ 2.75B¥ 2.11B
EBITDA
¥ 8.30B¥ 12.15B¥ 7.54B¥ 6.52B¥ 5.53B
Operating Income
¥ 4.99B¥ 3.88B¥ 3.86B¥ 3.78B¥ 3.35B
Other Income/Expenses
¥ -990.00M¥ 4.40B¥ 541.00M¥ -54.00M¥ 22.00M
Pretax Income
¥ 4.00B¥ 8.28B¥ 4.40B¥ 3.72B¥ 3.37B
Net Income
¥ 3.00B¥ 6.15B¥ 3.44B¥ 2.70B¥ 2.43B
Per Share Metrics
Basic EPS
¥ 122.93¥ 252.85¥ 141.35¥ 110.98¥ 90.52
Diluted EPS
¥ 122.93¥ 252.85¥ 141.35¥ 110.98¥ 90.52
Weighted Average Shares Outstanding
24.40M 24.31M 24.30M 24.29M 26.87M
Weighted Average Shares Outstanding (Diluted)
24.40M 24.31M 24.30M 24.29M 26.87M
Currency in JPY

Fuji Pharma Co., Ltd. Earnings and Revenue History